G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/18/2004	US20040228765 Point of care diagnostic platform
11/18/2004	US20040228761 Lateral flow test strip
11/18/2004	US20040228568 Target molecules detection by waveguiding in a photonic silicon membrane
11/18/2004	US20040227086 Method and device for NIR reflection spectroscopy
11/18/2004	US20040226885 using mass spectrometry; sample well having hydrophobic surface treatment
11/18/2004	US20040226822 Multi-dimensional electrophoresis apparatus
11/18/2004	US20040226392 Apparatus for detecting and reporting environmental conditions in bulk processing and handling of goods
11/18/2004	US20040226354 Method and device for the measurement of exhaust gas from internal combustion engines
11/18/2004	US20040226343 Test device for femoral head prosthesis
11/18/2004	DE202004013614U1 Sensor for spectrometric determination of e.g. carbon dioxide in drinks industry has housing containing radiation source and two detectors, front of housing consisting of inert inner insert and outer polymer matrix
11/18/2004	DE202004008088U1 Mobile phone alcohol sensor has inlet hole in phone housing and control and power supply shared with phone
11/18/2004	DE10319611A1 New conjugates useful as reagents for mass-spectrometric analysis of proteins, comprise a protein-reactive group covalently bound to an affinity ligand or solid phase through a linker
11/18/2004	DE10319592A1 Behandlung von diabetischer Retinopathie mit Angiotensin II-Rezeptorblockern Treatment of diabetic retinopathy with angiotensin II receptor blockers
11/18/2004	DE10318724A1 Test device for checking the quality of semi-finished textile products used to produce plastic components has a roving position for a predetermined orientation
11/18/2004	DE10318145B3 Instrument measuring moisture in building materials, especially in screeds, includes embedded probe connected with instrument measuring resistance
11/18/2004	DE10317400A1 EX-VIVO-Hautorganmodell aus Schweinehaut EX VIVO skin organ model from pig skin
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	DE10261650A1 Verwendung des multifunktionellen Transkriptionsfaktors Yin-Yang-1 und Varianten davon zur Behandlung von Erkrankungen, insbesondere von Typ-1 Diabetes Use of the multifunctional transcription factor Yin Yang 1 and variants thereof for the treatment of diseases, especially of type 1 diabetes
11/18/2004	DE102004006999A1 Gasmessfühler und Herstellungsverfahren dafür Gas sensor and manufacturing method thereof
11/18/2004	DE10110360B4 Verfahren zur Steuerung des Verarbeitungsablaufs in einer Schlacht- und Verarbeitungslinie Method for controlling the processing flow in a slaughtering and processing line
11/18/2004	CA2525029A1 Use of jag2 expression in diagnosis of plasma cell disorders
11/18/2004	CA2524680A1 Enrichment of enzymatic cleavage products
11/18/2004	CA2524669A1 Fluorescent methods for the high-throughput quantification of tartrate-resistant acid phosphatase (trap)
11/18/2004	CA2524655A1 Biomolecular devices
11/18/2004	CA2524579A1 Assay panel comprising food allergens
11/18/2004	CA2524393A1 Solid phase cell lysis and capture platform
11/18/2004	CA2524277A1 Arg-pro-pro-gly-phe analogs as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	CA2524266A1 Multicoated or multilayer entrapment matrix for protein biosensor
11/18/2004	CA2524261A1 Chromatographic assay system
11/18/2004	CA2524220A1 Multi-well plate providing a high-density storage and assay platform
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/18/2004	CA2524075A1 A method and apparatus for an advanced optical analyzer
11/18/2004	CA2523870A1 Claudins' underexpression as markers of tumor metastasis
11/18/2004	CA2523770A1 Method for identifying modulators of clk-1 and ubif activity
11/18/2004	CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	CA2523417A1 Method for storing tumor cells
11/18/2004	CA2516820A1 Nanocylinder-modified surfaces
11/17/2004	EP1477910A1 Apparatus for managing gene expression data
11/17/2004	EP1477809A1 Method for printing biomolecules
11/17/2004	EP1477808A1 Method for cell selection
11/17/2004	EP1477807A2 Method for determining the presence of inhibitors of thrombocytes in a blood sample
11/17/2004	EP1477806A1 Method of determining ligand
11/17/2004	EP1477805A1 Method for cell selection
11/17/2004	EP1477804A1 Instrument for separating plasma or serum, method of collecting plasma or serum, method of separating plasma or serum, test carrier and glass fiber
11/17/2004	EP1477803A1 Serum protein profiling for the diagnosis of epithelial cancers
11/17/2004	EP1477802A1 Method for selecting and producing vaccine components and vaccines based thereon
11/17/2004	EP1477801A1 Method and device for exhaust gas measurement of internal combustion engines
11/17/2004	EP1477792A2 Method and apparatus for purifying and desalting biological samples
11/17/2004	EP1477569A1 Method of quantifying glycosylated protein using redox reaction and quantification kit
11/17/2004	EP1477559A1 Novel polypeptide
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1477493A1 Isotope coded affinity tags
11/17/2004	EP1477185A2 Pneumococcal genes, portions thereof, expression products therefrom and uses of such genes, portions and products
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1476759A2 Diagnostic method for stroke
11/17/2004	EP1476758A2 Detection and/or monitoring of synuclein-related diseases
11/17/2004	EP1476757A1 Method and kit for predicting cancer
11/17/2004	EP1476756A1 Component for biological or biochemical analysis microfluidic system
11/17/2004	EP1476755A1 Composite material for a biological or biochemical analysis microfluidic system
11/17/2004	EP1476754A1 Irreversible colloidal chains with recognition sites
11/17/2004	EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004	EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
11/17/2004	EP1476751A2 Screening method
11/17/2004	EP1476750A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
11/17/2004	EP1476749A1 Device and method for determining parameters
11/17/2004	EP1476748A2 Gene function inferring using gene expression data
11/17/2004	EP1476747A2 Molecular hepatotoxicology modeling
11/17/2004	EP1476746A2 Method for discovering pharmacologically active substances
11/17/2004	EP1476745A1 Chromatographic method for determining the molecular weight distribution of an anionic polysaccharide
11/17/2004	EP1476582A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence
11/17/2004	EP1476580A2 Multiple virus replicon culture systems
11/17/2004	EP1476579A2 Method for reducing background contamination after marking reactions
11/17/2004	EP1476578A2 Mismatch repair detection
11/17/2004	EP1476576A2 Fluorogenic dyes
11/17/2004	EP1476575A2 Detection of single nucleotide polymorphisms using planar waveguides
11/17/2004	EP1476571A1 Complex comprising at least two biospecific elements separated by a nucleic acid linker e.g. for identification of drug delivery candidates. combinatorial library of such complexes
11/17/2004	EP1476568A2 Materials and methods relating to cancer diagnosis
11/17/2004	EP1476567A1 A method for the diagnosis of lymphoproliferative diseases
11/17/2004	EP1476565A2 Method for screening for compounds having hdac inhibitory activity
11/17/2004	EP1476560A2 Methods for the reduction of stutter in microsatellite amplification
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476536A1 Systems and methods for rapidly changing the solution environment around sensors
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476468A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
11/17/2004	EP1476467A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
11/17/2004	EP1476464A1 Variants of the alpha 1 subunit of human ampk
11/17/2004	EP1476462A2 Novel fungal lipase
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476223A1 Double gate transistor arrangement for receiving electrical signals from living cells
11/17/2004	EP1476218A2 Arrangement for receiving electrical signals from living cells and for the selective transmission of electrical stimulation to living cells
11/17/2004	EP1476200A2 Compositions and method for regulation of calcium-dependent signalling in brain
11/17/2004	EP1476182A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
11/17/2004	EP1476180A2 Interleukin-2 mutants with reduced toxicity
11/17/2004	EP1476179A2 Methods of preventing or treating brain ischemia or brain injury
11/17/2004	EP1476177A2 Peptide constructs for treating disease
11/17/2004	EP1476175A2 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476153A2 Method of treating and preventing bone loss

1 ... 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 ... 3937